Company Filing History:
Years Active: 2016-2022
Title: The Innovations of Philippe Guerry: A Leading Inventor in Pharmaceutical Research
Introduction
Philippe Guerry, based in Allschwil, Switzerland, is a prominent inventor with a remarkable portfolio of six patents. His work primarily focuses on the development of novel pharmaceutical compounds that target the CXCR7 receptor, a critical component in various therapeutic areas.
Latest Patents
Among his notable inventions is the patent for crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide. This invention concerns not only the crystalline forms of this compound but also processes for its preparation, as well as the pharmaceutical compositions that incorporate these forms for use as medicaments, particularly as CXCR7 receptor modulators. Another significant patent involves piperidine CXCR7 receptor modulators, which outlines piperidine derivatives, their preparation, and their applications in pharmaceutical compositions as CXCR7 receptor modulators.
Career Highlights
Philippe's career has been highlighted by his tenure at reputable pharmaceutical companies, including Idorsia Pharmaceuticals Ltd and Actelion Pharmaceuticals Ltd. His contributions in these roles have significantly advanced the field of pharmacology, particularly regarding the modulation of the CXCR7 receptor.
Collaborations
Throughout his career, Philippe has collaborated with esteemed colleagues such as Francois Lehembre and Julien Pothier. These partnerships have fostered innovation and led to breakthroughs in the development of new medicinal compounds.
Conclusion
Philippe Guerry's contributions to pharmaceutical innovations underscore the importance of research in developing effective therapeutic options. With several patents to his name, he continues to be a key figure in advancing medical science. His work exemplifies the profound impact inventors can have on healthcare and the ongoing quest to create novel medical treatments.